APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Banking and Blood Products

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Blood Banking and Blood Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025195 pages

Choose your research edition.

Industry ResearchBlood Banking and Blood Products Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Banking and Blood Products Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Blood Banking and Blood Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Banking and Blood Products Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Banking and Blood Products Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Blood Banking and Blood Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Blood Banking and Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Blood Banking and Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood Banking and Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Blood Banking and Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Blood Banking and Blood Products include Red Cross Society of China, Yuanda Shuyang, Weiguang Bio, Tiantan Bio, CBPO, Shuanglin Bio, RAAS, Nanyue Bio and Hualan Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Blood Banking and Blood Products market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Blood Banking and Blood Products and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood Banking and Blood Products revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Blood Banking and Blood Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Blood Banking and Blood Products Segment by Company

Red Cross Society of China

Yuanda Shuyang

Weiguang Bio

Tiantan Bio

CBPO

Shuanglin Bio

RAAS

Nanyue Bio

Hualan Bio

Boya Bio

Vitalant

Takeda

Sanquin Blood Supply Foundation

Octapharma

NHS Blood and Transplant

New York Blood Center

National Blood Transfusion Council

LFB Group

KM Biologics

Kedrion

Japan Red Cross Society

Grifols

CSL

Canadian Blood Services

BPL

Blood Bank of Alaska

Biotest

Australia Red Cross

American Red Cross

America’s Blood Centers

Blood Banking and Blood Products Segment by Type

RBCs

Whole Blood

Plasma

Plasma Fractionation Products

Plts

Blood Banking and Blood Products Segment by Application

Clinic

Hospital

Retail Pharmacy

Others

Blood Banking and Blood Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Banking and Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Banking and Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Banking and Blood Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Blood Banking and Blood Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Banking and Blood Products industry.

Chapter 3: Detailed analysis of Blood Banking and Blood Products companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Banking and Blood Productsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Blood Banking and Blood Products Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of RBCs Table 3. Key Players of Whole Blood Table 4. Key Players of Plasma Table 3. Key Players of Plasma Fractionation Products Table 4. Key Players of Plts Table 5. Global Blood Banking and Blood Products Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Clinic Table 7. Key Players of Hospital Table 8. Key Players of Retail Pharmacy Table 9. Key Players of Others Table 10. Global Blood Banking and Blood Products Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Blood Banking and Blood Products Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Blood Banking and Blood Products Market Share by Region (2021-2026) Table 13. Global Blood Banking and Blood Products Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Blood Banking and Blood Products Market Share by Region (2027-2032) Table 15. Blood Banking and Blood Products Industry Trends Table 16. Blood Banking and Blood Products Industry Drivers Table 17. Blood Banking and Blood Products Industry Opportunities and Challenges Table 18. Blood Banking and Blood Products Industry Restraints Table 19. Global Blood Banking and Blood Products Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Blood Banking and Blood Products Revenue Market Share by Company (2021-2026) Table 21. Global Blood Banking and Blood Products Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Blood Banking and Blood Products Key Company Head Office and Area Served Table 23. Global Blood Banking and Blood Products Company, Product Type & Application Table 24. Global Blood Banking and Blood Products Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Blood Banking and Blood Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Blood Banking and Blood Products Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Blood Banking and Blood Products Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Blood Banking and Blood Products Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Blood Banking and Blood Products Revenue Market Share by Type (2021-2026) Table 31. Global Blood Banking and Blood Products Revenue Market Share by Type (2027-2032) Table 32. Global Blood Banking and Blood Products Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Blood Banking and Blood Products Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Blood Banking and Blood Products Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Blood Banking and Blood Products Revenue Market Share by Application (2021-2026) Table 36. Global Blood Banking and Blood Products Revenue Market Share by Application (2027-2032) Table 37. Red Cross Society of China Company Information Table 38. Red Cross Society of China Business Overview Table 39. Red Cross Society of China Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Red Cross Society of China Blood Banking and Blood Products Product Portfolio Table 41. Red Cross Society of China Recent Development Table 42. Yuanda Shuyang Company Information Table 43. Yuanda Shuyang Business Overview Table 44. Yuanda Shuyang Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Yuanda Shuyang Blood Banking and Blood Products Product Portfolio Table 46. Yuanda Shuyang Recent Development Table 47. Weiguang Bio Company Information Table 48. Weiguang Bio Business Overview Table 49. Weiguang Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Weiguang Bio Blood Banking and Blood Products Product Portfolio Table 51. Weiguang Bio Recent Development Table 52. Tiantan Bio Company Information Table 53. Tiantan Bio Business Overview Table 54. Tiantan Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Tiantan Bio Blood Banking and Blood Products Product Portfolio Table 56. Tiantan Bio Recent Development Table 57. CBPO Company Information Table 58. CBPO Business Overview Table 59. CBPO Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. CBPO Blood Banking and Blood Products Product Portfolio Table 61. CBPO Recent Development Table 62. Shuanglin Bio Company Information Table 63. Shuanglin Bio Business Overview Table 64. Shuanglin Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Shuanglin Bio Blood Banking and Blood Products Product Portfolio Table 66. Shuanglin Bio Recent Development Table 67. RAAS Company Information Table 68. RAAS Business Overview Table 69. RAAS Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. RAAS Blood Banking and Blood Products Product Portfolio Table 71. RAAS Recent Development Table 72. Nanyue Bio Company Information Table 73. Nanyue Bio Business Overview Table 74. Nanyue Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Nanyue Bio Blood Banking and Blood Products Product Portfolio Table 76. Nanyue Bio Recent Development Table 77. Hualan Bio Company Information Table 78. Hualan Bio Business Overview Table 79. Hualan Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Hualan Bio Blood Banking and Blood Products Product Portfolio Table 81. Hualan Bio Recent Development Table 82. Boya Bio Company Information Table 83. Boya Bio Business Overview Table 84. Boya Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Boya Bio Blood Banking and Blood Products Product Portfolio Table 86. Boya Bio Recent Development Table 87. Vitalant Company Information Table 88. Vitalant Business Overview Table 89. Vitalant Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Vitalant Blood Banking and Blood Products Product Portfolio Table 91. Vitalant Recent Development Table 92. Takeda Company Information Table 93. Takeda Business Overview Table 94. Takeda Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Takeda Blood Banking and Blood Products Product Portfolio Table 96. Takeda Recent Development Table 97. Sanquin Blood Supply Foundation Company Information Table 98. Sanquin Blood Supply Foundation Business Overview Table 99. Sanquin Blood Supply Foundation Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Sanquin Blood Supply Foundation Blood Banking and Blood Products Product Portfolio Table 101. Sanquin Blood Supply Foundation Recent Development Table 102. Octapharma Company Information Table 103. Octapharma Business Overview Table 104. Octapharma Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. Octapharma Blood Banking and Blood Products Product Portfolio Table 106. Octapharma Recent Development Table 107. NHS Blood and Transplant Company Information Table 108. NHS Blood and Transplant Business Overview Table 109. NHS Blood and Transplant Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 110. NHS Blood and Transplant Blood Banking and Blood Products Product Portfolio Table 111. NHS Blood and Transplant Recent Development Table 112. New York Blood Center Company Information Table 113. New York Blood Center Business Overview Table 114. New York Blood Center Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 115. New York Blood Center Blood Banking and Blood Products Product Portfolio Table 116. New York Blood Center Recent Development Table 117. National Blood Transfusion Council Company Information Table 118. National Blood Transfusion Council Business Overview Table 119. National Blood Transfusion Council Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 120. National Blood Transfusion Council Blood Banking and Blood Products Product Portfolio Table 121. National Blood Transfusion Council Recent Development Table 122. LFB Group Company Information Table 123. LFB Group Business Overview Table 124. LFB Group Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 125. LFB Group Blood Banking and Blood Products Product Portfolio Table 126. LFB Group Recent Development Table 127. KM Biologics Company Information Table 128. KM Biologics Business Overview Table 129. KM Biologics Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 130. KM Biologics Blood Banking and Blood Products Product Portfolio Table 131. KM Biologics Recent Development Table 132. Kedrion Company Information Table 133. Kedrion Business Overview Table 134. Kedrion Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 135. Kedrion Blood Banking and Blood Products Product Portfolio Table 136. Kedrion Recent Development Table 137. Japan Red Cross Society Company Information Table 138. Japan Red Cross Society Business Overview Table 139. Japan Red Cross Society Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 140. Japan Red Cross Society Blood Banking and Blood Products Product Portfolio Table 141. Japan Red Cross Society Recent Development Table 142. Grifols Company Information Table 143. Grifols Business Overview Table 144. Grifols Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 145. Grifols Blood Banking and Blood Products Product Portfolio Table 146. Grifols Recent Development Table 147. CSL Company Information Table 148. CSL Business Overview Table 149. CSL Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 150. CSL Blood Banking and Blood Products Product Portfolio Table 151. CSL Recent Development Table 152. Canadian Blood Services Company Information Table 153. Canadian Blood Services Business Overview Table 154. Canadian Blood Services Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 155. Canadian Blood Services Blood Banking and Blood Products Product Portfolio Table 156. Canadian Blood Services Recent Development Table 157. BPL Company Information Table 158. BPL Business Overview Table 159. BPL Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 160. BPL Blood Banking and Blood Products Product Portfolio Table 161. BPL Recent Development Table 162. Blood Bank of Alaska Company Information Table 163. Blood Bank of Alaska Business Overview Table 164. Blood Bank of Alaska Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 165. Blood Bank of Alaska Blood Banking and Blood Products Product Portfolio Table 166. Blood Bank of Alaska Recent Development Table 167. Biotest Company Information Table 168. Biotest Business Overview Table 169. Biotest Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 170. Biotest Blood Banking and Blood Products Product Portfolio Table 171. Biotest Recent Development Table 172. Australia Red Cross Company Information Table 173. Australia Red Cross Business Overview Table 174. Australia Red Cross Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 175. Australia Red Cross Blood Banking and Blood Products Product Portfolio Table 176. Australia Red Cross Recent Development Table 177. American Red Cross Company Information Table 178. American Red Cross Business Overview Table 179. American Red Cross Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 180. American Red Cross Blood Banking and Blood Products Product Portfolio Table 181. American Red Cross Recent Development Table 182. America’s Blood Centers Company Information Table 183. America’s Blood Centers Business Overview Table 184. America’s Blood Centers Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 185. America’s Blood Centers Blood Banking and Blood Products Product Portfolio Table 186. America’s Blood Centers Recent Development Table 187. North America Blood Banking and Blood Products Market Size by Type (2021-2026) & (US$ Million) Table 188. North America Blood Banking and Blood Products Market Size by Type (2027-2032) & (US$ Million) Table 189. North America Blood Banking and Blood Products Market Size by Application (2021-2026) & (US$ Million) Table 190. North America Blood Banking and Blood Products Market Size by Application (2027-2032) & (US$ Million) Table 191. North America Blood Banking and Blood Products Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. North America Blood Banking and Blood Products Market Size by Country (2021-2026) Table 193. North America Blood Banking and Blood Products Market Size by Country (2027-2032) Table 194. Europe Blood Banking and Blood Products Market Size by Type (2021-2026) & (US$ Million) Table 195. Europe Blood Banking and Blood Products Market Size by Type (2027-2032) & (US$ Million) Table 196. Europe Blood Banking and Blood Products Market Size by Application (2021-2026) & (US$ Million) Table 197. Europe Blood Banking and Blood Products Market Size by Application (2027-2032) & (US$ Million) Table 198. Europe Blood Banking and Blood Products Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 199. Europe Blood Banking and Blood Products Market Size by Country (2021-2026) Table 200. Europe Blood Banking and Blood Products Market Size by Country (2027-2032) Table 201. China Blood Banking and Blood Products Market Size by Type (2021-2026) & (US$ Million) Table 202. China Blood Banking and Blood Products Market Size by Type (2027-2032) & (US$ Million) Table 203. China Blood Banking and Blood Products Market Size by Application (2021-2026) & (US$ Million) Table 204. China Blood Banking and Blood Products Market Size by Application (2027-2032) & (US$ Million) Table 205. Asia Blood Banking and Blood Products Market Size by Type (2021-2026) & (US$ Million) Table 206. Asia Blood Banking and Blood Products Market Size by Type (2027-2032) & (US$ Million) Table 207. Asia Blood Banking and Blood Products Market Size by Application (2021-2026) & (US$ Million) Table 208. Asia Blood Banking and Blood Products Market Size by Application (2027-2032) & (US$ Million) Table 209. Asia Blood Banking and Blood Products Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. Asia Blood Banking and Blood Products Market Size by Country (2021-2026) Table 211. Asia Blood Banking and Blood Products Market Size by Country (2027-2032) Table 212. South America, Middle East & Africa Blood Banking and Blood Products Market Size by Type (2021-2026) & (US$ Million) Table 213. South America, Middle East & Africa Blood Banking and Blood Products Market Size by Type (2027-2032) & (US$ Million) Table 214. South America, Middle East & Africa Blood Banking and Blood Products Market Size by Application (2021-2026) & (US$ Million) Table 215. South America, Middle East & Africa Blood Banking and Blood Products Market Size by Application (2027-2032) & (US$ Million) Table 216. South America, Middle East & Africa Blood Banking and Blood Products Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. South America, Middle East & Africa Blood Banking and Blood Products Market Size by Country (2021-2026) Table 218. South America, Middle East & Africa Blood Banking and Blood Products Market Size by Country (2027-2032) Table 219. Research Programs/Design for This Report Table 220. Authors List of This Report Table 221. Secondary Sources Table 222. Primary Sources List of Figures Figure 1. Blood Banking and Blood Products Product Image Figure 2. Global Blood Banking and Blood Products Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Blood Banking and Blood Products Market Share by Type: 2025 VS 2032 Figure 4. RBCs Image Figure 5. Whole Blood Image Figure 6. Plasma Image Figure 7. Plasma Fractionation Products Image Figure 8. Plts Image Figure 9. Global Blood Banking and Blood Products Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Blood Banking and Blood Products Market Share by Application: 2025 VS 2032 Figure 11. Clinic Image Figure 12. Hospital Image Figure 13. Retail Pharmacy Image Figure 14. Others Image Figure 15. Global Blood Banking and Blood Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 17. Global Blood Banking and Blood Products Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Blood Banking and Blood Products Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Blood Banking and Blood Products Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Blood Banking and Blood Products Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Blood Banking and Blood Products Revenue Market Share by Type (2021-2032) Figure 24. Global Blood Banking and Blood Products Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Blood Banking and Blood Products Revenue Market Share by Application (2021-2032) Figure 26. North America Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 27. North America Blood Banking and Blood Products Market Share by Type (2021-2032) Figure 28. North America Blood Banking and Blood Products Market Share by Application (2021-2032) Figure 29. North America Blood Banking and Blood Products Market Share by Country (2021-2032) Figure 30. United States Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 31. Canada Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 33. Europe Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 34. Europe Blood Banking and Blood Products Market Share by Type (2021-2032) Figure 35. Europe Blood Banking and Blood Products Market Share by Application (2021-2032) Figure 36. Europe Blood Banking and Blood Products Market Share by Country (2021-2032) Figure 37. Germany Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 38. France Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 40. Italy Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 41. Russia Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 43. China Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 44. China Blood Banking and Blood Products Market Share by Type (2021-2032) Figure 45. China Blood Banking and Blood Products Market Share by Application (2021-2032) Figure 46. Asia Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 47. Asia Blood Banking and Blood Products Market Share by Type (2021-2032) Figure 48. Asia Blood Banking and Blood Products Market Share by Application (2021-2032) Figure 49. Asia Blood Banking and Blood Products Market Share by Country (2021-2032) Figure 50. Japan Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 54. India Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 55. Australia Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Blood Banking and Blood Products Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Blood Banking and Blood Products Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Blood Banking and Blood Products Market Share by Country (2021-2032) Figure 60. Brazil Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 65. UAE Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 67. Chile Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • RBCs
  • Whole Blood
  • Plasma
  • Plasma Fractionation Products
  • Plts
Applications
  • Clinic
  • Hospital
  • Retail Pharmacy
  • Others
Companies covered
  • Red Cross Society of China
  • Yuanda Shuyang
  • Weiguang Bio
  • Tiantan Bio
  • CBPO
  • Shuanglin Bio
  • RAAS
  • Nanyue Bio
  • Hualan Bio
  • Boya Bio
  • Vitalant
  • Takeda
  • Sanquin Blood Supply Foundation
  • Octapharma
  • NHS Blood and Transplant
  • New York Blood Center
  • National Blood Transfusion Council
  • LFB Group
  • KM Biologics
  • Kedrion
  • Japan Red Cross Society
  • Grifols
  • CSL
  • Canadian Blood Services
  • BPL
  • Blood Bank of Alaska
  • Biotest
  • Australia Red Cross
  • American Red Cross
  • America’s Blood Centers

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Blood Banking and Blood Products Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 RBCs
  5. 1.2.3 Whole Blood
  6. 1.2.4 Plasma
  7. 1.2.5 Plasma Fractionation Products
  8. 1.2.6 Plts
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Blood Banking and Blood Products Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Clinic
  12. 1.3.3 Hospital
  13. 1.3.4 Retail Pharmacy
  14. 1.3.5 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Blood Banking and Blood Products Growth Trends by Region
  17. 1.5.1 Global Blood Banking and Blood Products Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Blood Banking and Blood Products Market Size by Region (2021-2026)
  19. 1.5.3 Blood Banking and Blood Products Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Blood Banking and Blood Products Market Dynamics
  1. 2.1 Blood Banking and Blood Products Industry Trends
  2. 2.2 Blood Banking and Blood Products Industry Drivers
  3. 2.3 Blood Banking and Blood Products Industry Opportunities and Challenges
  4. 2.4 Blood Banking and Blood Products Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Blood Banking and Blood Products Revenue by Company (2021-2026)
  2. 3.2 Global Blood Banking and Blood Products Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Blood Banking and Blood Products Key Company Head office and Area Served
  4. 3.4 Global Blood Banking and Blood Products Company, Product Type & Application
  5. 3.5 Global Blood Banking and Blood Products Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Blood Banking and Blood Products Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Blood Banking and Blood Products Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Blood Banking and Blood Products Tier 1, Tier 2, and Tier 3
4 Blood Banking and Blood Products Market by Type
  1. 4.1 Global Blood Banking and Blood Products Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Blood Banking and Blood Products Market Size by Type (2021-2032)
  3. 4.3 Global Blood Banking and Blood Products Market Size Share by Type (2021-2032)
5 Blood Banking and Blood Products Market by Application
  1. 5.1 Global Blood Banking and Blood Products Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Blood Banking and Blood Products Market Size by Application (2021-2032)
  3. 5.3 Global Blood Banking and Blood Products Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Red Cross Society of China
  2. 6.1.1 Red Cross Society of China Company Information
  3. 6.1.2 Red Cross Society of China Business Overview
  4. 6.1.3 Red Cross Society of China Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Red Cross Society of China Blood Banking and Blood Products Product Portfolio
  6. 6.1.5 Red Cross Society of China Recent Developments
  7. 6.2 Yuanda Shuyang
  8. 6.2.1 Yuanda Shuyang Company Information
  9. 6.2.2 Yuanda Shuyang Business Overview
  10. 6.2.3 Yuanda Shuyang Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Yuanda Shuyang Blood Banking and Blood Products Product Portfolio
  12. 6.2.5 Yuanda Shuyang Recent Developments
  13. 6.3 Weiguang Bio
  14. 6.3.1 Weiguang Bio Company Information
  15. 6.3.2 Weiguang Bio Business Overview
  16. 6.3.3 Weiguang Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Weiguang Bio Blood Banking and Blood Products Product Portfolio
  18. 6.3.5 Weiguang Bio Recent Developments
  19. 6.4 Tiantan Bio
  20. 6.4.1 Tiantan Bio Company Information
  21. 6.4.2 Tiantan Bio Business Overview
  22. 6.4.3 Tiantan Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Tiantan Bio Blood Banking and Blood Products Product Portfolio
  24. 6.4.5 Tiantan Bio Recent Developments
  25. 6.5 CBPO
  26. 6.5.1 CBPO Company Information
  27. 6.5.2 CBPO Business Overview
  28. 6.5.3 CBPO Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 CBPO Blood Banking and Blood Products Product Portfolio
  30. 6.5.5 CBPO Recent Developments
  31. 6.6 Shuanglin Bio
  32. 6.6.1 Shuanglin Bio Company Information
  33. 6.6.2 Shuanglin Bio Business Overview
  34. 6.6.3 Shuanglin Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Shuanglin Bio Blood Banking and Blood Products Product Portfolio
  36. 6.6.5 Shuanglin Bio Recent Developments
  37. 6.7 RAAS
  38. 6.7.1 RAAS Company Information
  39. 6.7.2 RAAS Business Overview
  40. 6.7.3 RAAS Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 RAAS Blood Banking and Blood Products Product Portfolio
  42. 6.7.5 RAAS Recent Developments
  43. 6.8 Nanyue Bio
  44. 6.8.1 Nanyue Bio Company Information
  45. 6.8.2 Nanyue Bio Business Overview
  46. 6.8.3 Nanyue Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Nanyue Bio Blood Banking and Blood Products Product Portfolio
  48. 6.8.5 Nanyue Bio Recent Developments
  49. 6.9 Hualan Bio
  50. 6.9.1 Hualan Bio Company Information
  51. 6.9.2 Hualan Bio Business Overview
  52. 6.9.3 Hualan Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Hualan Bio Blood Banking and Blood Products Product Portfolio
  54. 6.9.5 Hualan Bio Recent Developments
  55. 6.10 Boya Bio
  56. 6.10.1 Boya Bio Company Information
  57. 6.10.2 Boya Bio Business Overview
  58. 6.10.3 Boya Bio Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Boya Bio Blood Banking and Blood Products Product Portfolio
  60. 6.10.5 Boya Bio Recent Developments
  61. 6.11 Vitalant
  62. 6.11.1 Vitalant Company Information
  63. 6.11.2 Vitalant Business Overview
  64. 6.11.3 Vitalant Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Vitalant Blood Banking and Blood Products Product Portfolio
  66. 6.11.5 Vitalant Recent Developments
  67. 6.12 Takeda
  68. 6.12.1 Takeda Company Information
  69. 6.12.2 Takeda Business Overview
  70. 6.12.3 Takeda Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Takeda Blood Banking and Blood Products Product Portfolio
  72. 6.12.5 Takeda Recent Developments
  73. 6.13 Sanquin Blood Supply Foundation
  74. 6.13.1 Sanquin Blood Supply Foundation Company Information
  75. 6.13.2 Sanquin Blood Supply Foundation Business Overview
  76. 6.13.3 Sanquin Blood Supply Foundation Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Sanquin Blood Supply Foundation Blood Banking and Blood Products Product Portfolio
  78. 6.13.5 Sanquin Blood Supply Foundation Recent Developments
  79. 6.14 Octapharma
  80. 6.14.1 Octapharma Company Information
  81. 6.14.2 Octapharma Business Overview
  82. 6.14.3 Octapharma Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Octapharma Blood Banking and Blood Products Product Portfolio
  84. 6.14.5 Octapharma Recent Developments
  85. 6.15 NHS Blood and Transplant
  86. 6.15.1 NHS Blood and Transplant Company Information
  87. 6.15.2 NHS Blood and Transplant Business Overview
  88. 6.15.3 NHS Blood and Transplant Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 NHS Blood and Transplant Blood Banking and Blood Products Product Portfolio
  90. 6.15.5 NHS Blood and Transplant Recent Developments
  91. 6.16 New York Blood Center
  92. 6.16.1 New York Blood Center Company Information
  93. 6.16.2 New York Blood Center Business Overview
  94. 6.16.3 New York Blood Center Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 New York Blood Center Blood Banking and Blood Products Product Portfolio
  96. 6.16.5 New York Blood Center Recent Developments
  97. 6.17 National Blood Transfusion Council
  98. 6.17.1 National Blood Transfusion Council Company Information
  99. 6.17.2 National Blood Transfusion Council Business Overview
  100. 6.17.3 National Blood Transfusion Council Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 National Blood Transfusion Council Blood Banking and Blood Products Product Portfolio
  102. 6.17.5 National Blood Transfusion Council Recent Developments
  103. 6.18 LFB Group
  104. 6.18.1 LFB Group Company Information
  105. 6.18.2 LFB Group Business Overview
  106. 6.18.3 LFB Group Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 LFB Group Blood Banking and Blood Products Product Portfolio
  108. 6.18.5 LFB Group Recent Developments
  109. 6.19 KM Biologics
  110. 6.19.1 KM Biologics Company Information
  111. 6.19.2 KM Biologics Business Overview
  112. 6.19.3 KM Biologics Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 KM Biologics Blood Banking and Blood Products Product Portfolio
  114. 6.19.5 KM Biologics Recent Developments
  115. 6.20 Kedrion
  116. 6.20.1 Kedrion Company Information
  117. 6.20.2 Kedrion Business Overview
  118. 6.20.3 Kedrion Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Kedrion Blood Banking and Blood Products Product Portfolio
  120. 6.20.5 Kedrion Recent Developments
  121. 6.21 Japan Red Cross Society
  122. 6.21.1 Japan Red Cross Society Company Information
  123. 6.21.2 Japan Red Cross Society Business Overview
  124. 6.21.3 Japan Red Cross Society Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Japan Red Cross Society Blood Banking and Blood Products Product Portfolio
  126. 6.21.5 Japan Red Cross Society Recent Developments
  127. 6.22 Grifols
  128. 6.22.1 Grifols Company Information
  129. 6.22.2 Grifols Business Overview
  130. 6.22.3 Grifols Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 Grifols Blood Banking and Blood Products Product Portfolio
  132. 6.22.5 Grifols Recent Developments
  133. 6.23 CSL
  134. 6.23.1 CSL Company Information
  135. 6.23.2 CSL Business Overview
  136. 6.23.3 CSL Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 CSL Blood Banking and Blood Products Product Portfolio
  138. 6.23.5 CSL Recent Developments
  139. 6.24 Canadian Blood Services
  140. 6.24.1 Canadian Blood Services Company Information
  141. 6.24.2 Canadian Blood Services Business Overview
  142. 6.24.3 Canadian Blood Services Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  143. 6.24.4 Canadian Blood Services Blood Banking and Blood Products Product Portfolio
  144. 6.24.5 Canadian Blood Services Recent Developments
  145. 6.25 BPL
  146. 6.25.1 BPL Company Information
  147. 6.25.2 BPL Business Overview
  148. 6.25.3 BPL Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  149. 6.25.4 BPL Blood Banking and Blood Products Product Portfolio
  150. 6.25.5 BPL Recent Developments
  151. 6.26 Blood Bank of Alaska
  152. 6.26.1 Blood Bank of Alaska Company Information
  153. 6.26.2 Blood Bank of Alaska Business Overview
  154. 6.26.3 Blood Bank of Alaska Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  155. 6.26.4 Blood Bank of Alaska Blood Banking and Blood Products Product Portfolio
  156. 6.26.5 Blood Bank of Alaska Recent Developments
  157. 6.27 Biotest
  158. 6.27.1 Biotest Company Information
  159. 6.27.2 Biotest Business Overview
  160. 6.27.3 Biotest Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  161. 6.27.4 Biotest Blood Banking and Blood Products Product Portfolio
  162. 6.27.5 Biotest Recent Developments
  163. 6.28 Australia Red Cross
  164. 6.28.1 Australia Red Cross Company Information
  165. 6.28.2 Australia Red Cross Business Overview
  166. 6.28.3 Australia Red Cross Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  167. 6.28.4 Australia Red Cross Blood Banking and Blood Products Product Portfolio
  168. 6.28.5 Australia Red Cross Recent Developments
  169. 6.29 American Red Cross
  170. 6.29.1 American Red Cross Company Information
  171. 6.29.2 American Red Cross Business Overview
  172. 6.29.3 American Red Cross Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  173. 6.29.4 American Red Cross Blood Banking and Blood Products Product Portfolio
  174. 6.29.5 American Red Cross Recent Developments
  175. 6.30 America’s Blood Centers
  176. 6.30.1 America’s Blood Centers Company Information
  177. 6.30.2 America’s Blood Centers Business Overview
  178. 6.30.3 America’s Blood Centers Blood Banking and Blood Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  179. 6.30.4 America’s Blood Centers Blood Banking and Blood Products Product Portfolio
  180. 6.30.5 America’s Blood Centers Recent Developments
7 North America
  1. 7.1 North America Blood Banking and Blood Products Market Size (2021-2032)
  2. 7.2 North America Blood Banking and Blood Products Market Size by Type
  3. 7.2.1 North America Blood Banking and Blood Products Market Size by Type (2021-2026)
  4. 7.2.2 North America Blood Banking and Blood Products Market Size by Type (2027-2032)
  5. 7.2.3 North America Blood Banking and Blood Products Market Share by Type (2021-2032)
  6. 7.3 North America Blood Banking and Blood Products Market Size by Application
  7. 7.3.1 North America Blood Banking and Blood Products Market Size by Application (2021-2026)
  8. 7.3.2 North America Blood Banking and Blood Products Market Size by Application (2027-2032)
  9. 7.3.3 North America Blood Banking and Blood Products Market Share by Application (2021-2032)
  10. 7.4 North America Blood Banking and Blood Products Market Size by Country
  11. 7.4.1 North America Blood Banking and Blood Products Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Blood Banking and Blood Products Market Size by Country (2021-2026)
  13. 7.4.3 North America Blood Banking and Blood Products Market Size by Country (2027-2032)
  14. 7.4.4 North America Blood Banking and Blood Products Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Blood Banking and Blood Products Market Size (2021-2032)
  2. 8.2 Europe Blood Banking and Blood Products Market Size by Type
  3. 8.2.1 Europe Blood Banking and Blood Products Market Size by Type (2021-2026)
  4. 8.2.2 Europe Blood Banking and Blood Products Market Size by Type (2027-2032)
  5. 8.2.3 Europe Blood Banking and Blood Products Market Share by Type (2021-2032)
  6. 8.3 Europe Blood Banking and Blood Products Market Size by Application
  7. 8.3.1 Europe Blood Banking and Blood Products Market Size by Application (2021-2026)
  8. 8.3.2 Europe Blood Banking and Blood Products Market Size by Application (2027-2032)
  9. 8.3.3 Europe Blood Banking and Blood Products Market Share by Application (2021-2032)
  10. 8.4 Europe Blood Banking and Blood Products Market Size by Country
  11. 8.4.1 Europe Blood Banking and Blood Products Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Blood Banking and Blood Products Market Size by Country (2021-2026)
  13. 8.4.3 Europe Blood Banking and Blood Products Market Size by Country (2027-2032)
  14. 8.4.4 Europe Blood Banking and Blood Products Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Blood Banking and Blood Products Market Size (2021-2032)
  2. 9.2 China Blood Banking and Blood Products Market Size by Type
  3. 9.2.1 China Blood Banking and Blood Products Market Size by Type (2021-2026)
  4. 9.2.2 China Blood Banking and Blood Products Market Size by Type (2027-2032)
  5. 9.2.3 China Blood Banking and Blood Products Market Share by Type (2021-2032)
  6. 9.3 China Blood Banking and Blood Products Market Size by Application
  7. 9.3.1 China Blood Banking and Blood Products Market Size by Application (2021-2026)
  8. 9.3.2 China Blood Banking and Blood Products Market Size by Application (2027-2032)
  9. 9.3.3 China Blood Banking and Blood Products Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Blood Banking and Blood Products Market Size (2021-2032)
  2. 10.2 Asia Blood Banking and Blood Products Market Size by Type
  3. 10.2.1 Asia Blood Banking and Blood Products Market Size by Type (2021-2026)
  4. 10.2.2 Asia Blood Banking and Blood Products Market Size by Type (2027-2032)
  5. 10.2.3 Asia Blood Banking and Blood Products Market Share by Type (2021-2032)
  6. 10.3 Asia Blood Banking and Blood Products Market Size by Application
  7. 10.3.1 Asia Blood Banking and Blood Products Market Size by Application (2021-2026)
  8. 10.3.2 Asia Blood Banking and Blood Products Market Size by Application (2027-2032)
  9. 10.3.3 Asia Blood Banking and Blood Products Market Share by Application (2021-2032)
  10. 10.4 Asia Blood Banking and Blood Products Market Size by Country
  11. 10.4.1 Asia Blood Banking and Blood Products Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Blood Banking and Blood Products Market Size by Country (2021-2026)
  13. 10.4.3 Asia Blood Banking and Blood Products Market Size by Country (2027-2032)
  14. 10.4.4 Asia Blood Banking and Blood Products Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Blood Banking and Blood Products Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Blood Banking and Blood Products Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Blood Banking and Blood Products Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Blood Banking and Blood Products Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Blood Banking and Blood Products Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst